Sonia Maciá is an ESMO-certified medical oncologist. She obtained a master’s degree in pharmacoeconomics from Universitat Pompeu Fabra Barcelona and a Ph.D. in lung cancer from the University Miguel Hernández. She has an Executive MBA from EAE/University of Barcelona. Dr. Maciá worked as a practicing medical oncologist for nine years and then decided to devote her career to clinical research. After working for different CROs, she joined Highlight Therapeutics to work on clinical development for intratumoral immunotherapies. Currently, Dr. Maciá is Executive Medical Director at LAVA Therapeutics, working on early development with several immunotherapies for solid and hematologic malignancies. Dr. Maciá has submitted more than 40 abstracts to international conferences, published more than 30 papers in peer-reviewed journals, and authored six book chapters.